3
Hyderabad- and US-based biotech startup Helex has raised $3.5 million in a seed round led by pi Ventures, with participation from Bluehill Capital, SOSV, and other global investors.
The startup is developing targeted genomic medicines for kidney diseases using its proprietary lipid nanoparticle (LNP) delivery and artificial intelligence (AI)-driven drug design platforms.
Incubated at ASPIRE–BioNEST, University of Hyderabad, Helex aims to make gene therapies more precise, accessible, and affordable, its founders told ET.
The funding will accelerate…
